Bumetanide and Multiple sclerosis - a phase IV clinical study of FDA data


Multiple sclerosis is found among people who take Bumetanide, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Bumetanide and have Multiple sclerosis. It is created by eHealthMe based on reports of 17,150 people who have side effects when taking Bumetanide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2022

17,150 people reported to have side effects when taking Bumetanide.
Among them, 17 people (0.1%) have Multiple sclerosis.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 17,317 Bumetanide users for its effectiveness, alternative drugs and more.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 2,058 drugs and 1,281 conditions by eHealthMe.

Number of Bumetanide and Multiple sclerosis reports submitted per year:

Could Bumetanide cause Multiple sclerosis?

Gender of people who have Multiple sclerosis when taking Bumetanide *:

  • female: 88.24 %
  • male: 11.76 %

Age of people who have Multiple sclerosis when taking Bumetanide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.14 %
  • 50-59: 35.71 %
  • 60+: 57.14 %

Common drugs people take besides Bumetanide *:

  1. Ampyra: 7 people, 41.18%
  2. Tysabri: 5 people, 29.41%
  3. Hibiclens: 4 people, 23.53%
  4. Eliquis: 4 people, 23.53%
  5. Tecfidera: 3 people, 17.65%
  6. Flomax: 3 people, 17.65%
  7. Fish Oil: 3 people, 17.65%
  8. Aubagio: 3 people, 17.65%
  9. Nuedexta: 2 people, 11.76%
  10. Ocrevus: 2 people, 11.76%

Common side effects people have besides Multiple sclerosis *:

  1. Fall: 9 people, 52.94%
  2. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 29.41%
  3. Peripheral Swelling: 5 people, 29.41%
  4. Rashes (redness): 5 people, 29.41%
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 5 people, 29.41%
  6. Hypotension (abnormally low blood pressure): 5 people, 29.41%
  7. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 23.53%
  8. Loss Of Consciousness: 4 people, 23.53%
  9. Itching: 4 people, 23.53%
  10. Burning Sensation: 4 people, 23.53%

Common conditions people have *:

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.76%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.88%
  3. Depression: 1 person, 5.88%
  4. Asthma: 1 person, 5.88%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.88%
  6. Bowel Movement Irregularity: 1 person, 5.88%
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.88%
  8. Cardiac Arrest: 1 person, 5.88%
  9. Cardiac Disorder: 1 person, 5.88%
  10. Gait Disturbance: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Multiple sclerosis?

Check whether Multiple sclerosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Multiple sclerosis and when was it recovered:

Expand to all the drugs that have ingredients of bumetanide:

Alternative drugs to, pros and cons of Bumetanide:

Common Bumetanide side effects:

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Multiple sclerosis treatments and more:

COVID vaccines that are related to Multiple sclerosis:

Common drugs associated with Multiple sclerosis:

All the drugs that are associated with Multiple sclerosis:

Common conditions associated with Multiple sclerosis:

All the conditions that are associated with Multiple sclerosis:

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: